This research paper – by Joel Methorsta, Aletta Bonn, Melissa Marselle, Katrin Böhning-Gaese, and Katrin Rehdanz – has been published in the journal Landscape and Urban Planning. “Highlights National epidemiological study on relationship between biodiversity and human health.Plant and bird species richness…
Read more
Rachel Schraer reports for the BBC: “Dr Carhart-Harris said that after psychedelic therapy, participants reported feeling ‘recalibrated, reset like they haven’t for years” and “enjoying life’.” “Psychedelic drug psilocybin, found in magic mushrooms, is as good at reducing symptoms of depression…
Read more
“Martin Harrow and Thomas Jobe began their study, which was funded by the National Institute of Mental Health, in the late 1970s. They enrolled 200 psychotic patients who had been treated conventionally in a mental hospital with antipsychotics and simply…
Read more
Chiara Giordano reports for The Independent: “Taking MDMA could help treat alcohol addiction , according to a new study. During an eight-week trial in Bristol, 14 people with alcohol problems were given a controlled amount of the party drug, also known as ecstasy , during…
Read more
The National Centre for Creative Health (NCCH) – a new organisation – has arisen from a two-year inquiry by the UK’s All-Party Parliamentary Group (APPG) for Arts, Health and Wellbeing. The inquiry led to the publication of the Creative Health report in 2017. Since then, the APPG…
Read more
“The fact that psilocybin is classified as a Class A drug means there has been a research blackout for nearly 50 years into the beneficial effect it can have in improving the lives of people suffering from PTSD and depression.”Arfon…
Read more